Dissemination (Meeting Coverage)

In patients with aged 10-17 and treated with fingolimod for up to 6 years in the PARADIGMS study,...

From observational, single-arm cohorts, autologous hematopoietic stem cell transplantation (AHSCT)...

At a prize-winning poster presented at the European Committee for Treatment and Research in...

A large study conducted in European nationwide data sources found no evidence that teriflunomide...

West Virginia has widespread cardiovascular disease (CVD), which may be associated with ancestry...

ASCVD is the primary cause of death for women despite having a later onset than it is for men, and...

The ORION-1 experiment showed that inclisiran, an RNAi treatment that prevents PCSK9 production in...

Although there are many genetic polymorphisms in the APOB gene, it is not known whether or not...

Patients (pts) who received methotrexate (MTX) in combination with placebo [PBO] co-therapy to...

It is impossible to meet the requirements of a community as a whole by developing the capacity to...

Emerging data from US cohort studies imply that the costs of gout and hyperuricemia are...

For the treatment of gout in chronic kidney disease CKD patients, there needs to be more...

Hyperuricemia and the accompanying deposition of aggregated monosodium urate (MSU) crystals in...

Reliable detection and measurement of monosodium urate (MSU) crystal deposits in gout patients can...

Gout, chronic kidney disease, type 2 diabetes, and cardiovascular disease are all linked to...

Pegloticase’s effectiveness is dramatically enhanced when immunomodulator co-therapy is used...

Changes in cholesterol metabolism may be linked to the progression of multiple sclerosis (MS)...

Active primary progressive multiple sclerosis (PPMS) has effective treatment options, thus...

All multiple sclerosis (MS) patients should have the COVID-19 vaccine, as suggested by the...

For patients with relapsing-remitting multiple sclerosis (MS), teriflunomide (TF) is a...